Cancellation of state registration. Hemofer prolongatum

May 29, 2017

Active substances:

Iron sulfate

Trade names:

Hemofer® Prolongatum

ICD-10:

III.D50-D53.D50 Iron-deficiency anemia

III.D50-D53.D51 Vitamin-B12-deficiency anemia

IV.E50-E64.E61.1 Insufficiency of iron

XV.O95-O99.O99.0 Anemia complicating pregnancy, childbirth and the puerperium

Hemofer prolongatum, iron sulfate, treatment of anemia, iron deficiency anemia, iron deficiency, B12-deficiency anemia, prevention of anemia in pregnancy

The Ministry of Health of the Russian Federation in accordance with Article 32Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate No. N012020 / 01 dated 12.05.2008 issued by GlaxoSmithKline Trading ", Russia):

Hemofer prolongatum (trade name of the medicinal product)

Iron sulfate (international non-patented or batch or chemical name)

pills, 325 mg (dosage form, dosage)

GlaxoSmithKline Pharmaceuticals SA, Poland Ul. Grunwaldzka 189, 60-322, Poznan, Poland (name and address of the location of the manufacturer of the medicinal product)

on the basis of a filing by an authorized legal entity of ZAO GlaxoSmithKline Trading, an application for the cancellation of the state registration of a medicinal product.